A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial
Kamba, Tomomi, Kamoto, Toshiyuki, Maruo, Shinichiro, Kikuchi, Takashi, Shimizu, Yosuke, Namiki, Shunichi, Fujimoto, Kiyohide, Kawanishi, Hiroaki, Sato, Fuminori, Narita, Shintaro, Satoh, Takefumi, SaiVolume:
22
Language:
english
Journal:
International Journal of Clinical Oncology
DOI:
10.1007/s10147-016-1037-2
Date:
February, 2017
File:
PDF, 1016 KB
english, 2017